Literature DB >> 6708017

Outcome of a trial of labor after prior cesarean delivery.

G S Eglinton, J P Phelan, S Yeh, F P Diaz, T M Wallace, R H Paul.   

Abstract

In the United States over 90% of patients with a history of cesarean delivery in the prior pregnancy undergo repeat cesarean delivery in a subsequent pregnancy. The costs of the nearly universal approach to this issue are staggering and have been addressed by a recent National Institutes of Health consensus development conference. In 1979 at the Women's Hospital of Los Angeles County/University of Southern California Medical Center we initiated a policy of permitting a trial of spontaneous labor and vaginal delivery in selected patients with prior cesarean deliveries. Patients selected for a trial of labor (TOL) were those with a history of one prior uterine incision known to be low transverse. During 1980 there were 13,292 deliveries and 13,147 live births; 871 of these patients had a history of prior cesarean delivery. Of the 871 women, 308 (35%) were permitted a TOL. There were 240 vaginal deliveries, for a success rate of 78%. Twenty-two perinatal deaths occurred among the 871 patients, none directly attributable to the TOL. There were three ruptured uteri, one directly attributable to a TOL. Seven hysterectomies were performed in this group, none directly attributable to a TOL. This experience has encouraged us to expand the patient group offered a TOL after prior cesarean delivery under carefully controlled conditions.

Entities:  

Mesh:

Year:  1984        PMID: 6708017

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

1.  Obstetrics and gynecology: vaginal delivery after previous cesarean section.

Authors:  J P Phelan
Journal:  West J Med       Date:  1986-01

2.  VBAC: Is It Safe for Your Patients?

Authors:  A J Reid
Journal:  Can Fam Physician       Date:  1986-10       Impact factor: 3.275

3.  Delivery after prior cesarean: maternal morbidity and mortality.

Authors:  Yvonne W Cheng; Karen B Eden; Nicole Marshall; Leonardo Pereira; Aaron B Caughey; Jeanne-Marie Guise
Journal:  Clin Perinatol       Date:  2011-06       Impact factor: 3.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.